Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 3/20 | 0.37 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.37 |
| ▸ | SHBG | P04278 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8003990 | 1.00 | SRD5A1 (0.37) | SRD5A1SRD5A2SHBG | |
| SCHEMBL8003663 | 0.92 | SRD5A1 (0.37) | SRD5A1SRD5A2SHBG | |
| SCHEMBL8003658 | 0.92 | SRD5A1 (0.37) | SRD5A1SRD5A2SHBG | |
| SCHEMBL8008926 | 0.89 | SRD5A1 (0.35) | SRD5A1SRD5A2SHBG | |
| SCHEMBL8009015 | 0.89 | SRD5A1 (0.35) | SRD5A1SRD5A2SHBG | |
| SCHEMBL8003413 | 0.85 | SRD5A1 (0.36) | SRD5A1SRD5A2SHBG | |
| SCHEMBL8003121 | 0.83 | SRD5A1 (0.37) | SRD5A1SRD5A2SHBG | |
| SCHEMBL8003971 | 0.83 | SRD5A1 (0.37) | SRD5A1SRD5A2SHBG | |
| SCHEMBL8003952 | 0.83 | SRD5A1 (0.37) | SRD5A1SRD5A2SHBG | |
| SCHEMBL8325001 | 0.83 | SRD5A1 (0.37) | SRD5A1SRD5A2SHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5998464-A | 4-Oxa and 4-thia steroids | MERCK & CO., INC. (US) | 1999-12-07 | — | — | US | claimed |
| US-5998464-A | 4-Oxa and 4-thia steroids | MERCK & CO., INC. (US) | 1999-12-07 | — | — | US | disclosed |
| US-5932559-A | Treatment of hyperandrogenic conditions | MERCK & CO., INC. (US) | 1999-08-03 | — | — | US | disclosed |
| US-5777134-A | 4-oxa and 4-thia steriods | MERCK & CO., INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5756480-A | Treatment of hyperandrogenic conditions | MERCK & CO., INC. (US) | 1998-05-26 | — | — | US | disclosed |
| WO-1997015305-A1 | TREATMENT OF HYPERANDROGENIC CONDITIONS | MERCK & CO., INC. (US) | 1997-05-01 | — | — | WO | disclosed |